1. Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysis. Issue 6 (30th January 2022) Authors: Chazan, Grace; Anton, Angelyn; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew; Azad, Arun; Kwan, Edmond M; Spain, Lavinia; Gunjur, Ashray; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Gibbs, Peter; Tran, Ben Journal: Asia-Pacific journal of clinical oncology Issue: Volume 18:Issue 6(2022) Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry. (October 2022) Authors: Santucci, Jordan; Tacey, Mark; Thomson, Benjamin; Michael, Michael; Wong, Rachel; Shapiro, Julia; Jennens, Ross; Clarke, Kate; Pattison, Sharon; Burge, Matthew; Zielinski, Rob; Nikfarjam, Mehrdad; Ananda, Sumitra; Lipton, Lara; Gibbs, Peter; Lee, Belinda Journal: European journal of cancer Issue: Volume 174(2022) Page Start: 102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Prostate‐specific membrane antigen positron emission tomography‐computed tomography use prior to systemic therapy in metastatic castration‐resistant prostate cancer. (30th November 2022) Authors: Kelly, Richard; Jensen, Andrew; Karunaratna, Nathasha; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew; Parente, Phillip; Azad, Arun A.; Uccellini, Anthony; Torres, Javier; Parnis, Francis; Goh, Jeffrey; Kwan, Edmond M.; Brown, Stephen; Steer, Christopher; Warren, Mark; Gibbs, Peter; Tran, Ben;... Journal: BJU international Issue: Volume 131:Number 2(2023) Page Start: 179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?. (7th February 2023) Authors: Pereira-Salgado, Amanda; Anton, Angelyn; Franchini, Fanny; Mahar, Robert K.; Kwan, Edmond M.; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew; Azad, Arun A.; Spain, Lavinia; Gunjur, Ashray; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Steer, Christopher; Brown, Stephen; Gibb... Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 23:Number 2(2023) Page Start: 231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Real-world incidence of symptomatic skeletal events and bone-modifying agent use in castration-resistant prostate cancer – an Australian multi-centre observational study. (November 2021) Authors: Anton, Angelyn; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew; Azad, Arun; Kwan, Edmond M.; Spain, Lavinia; Gunjur, Ashray; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Semira, Marie C.; Gibbs, Peter; Tran, Ben; Pezaro, Carmel Journal: European journal of cancer Issue: Volume 157(2021) Page Start: 485 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Real‐world first‐line systemic therapy patterns in metastatic castration‐resistant prostate cancer. Issue 3 (14th December 2021) Authors: Anton, Angelyn; Pillai, Sruti; Semira, Marie Christine; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew; Azad, Arun; Kwan, Edmond M.; Spain, Lavinia; Gunjur, Ashray; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Baenziger, Olivia; Gibbs, Peter; Tran, Ben Journal: BJUI Compass Issue: Volume 3:Issue 3(2022) Page Start: 205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Real‐world use of first‐generation antiandrogens: impact on patient outcomes and subsequent therapies in metastatic castration‐resistant prostate cancer. Issue Volume 128:Issue Supplement 1(2021) (7th October 2021) Authors: Kelly, Richard; Anton, Angelyn; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew; Azad, Arun; Kwan, Edmond Michael; Spain, Lavinia; Muthusamy, Arun; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Joshua, Anthony; Pook, David; Baenziger, Olivia; Gibbs, Peter; Tran, Ben Journal: BJU international Issue: Volume 128:Issue Supplement 1(2021) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Treatment and outcomes of unresectable and metastatic pancreatic cancer treated in public and private Australian hospitals. Issue 4 (23rd November 2021) Authors: To, Yat Hang; Shapiro, Julia; Wong, Rachel; Thomson, Benjamin; Nagrial, Adnan; Mendis, Shehara; Gibbs, Peter; Shapiro, Jeremy; Lee, Belinda Journal: Asia-Pacific journal of clinical oncology Issue: Volume 18:Issue 4(2022) Page Start: 448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Treatment outcomes for patients with metastatic castrate‐resistant prostate cancer following docetaxel for hormone‐sensitive disease. Issue 1 (24th September 2020) Authors: Schmidt, Andrew; Anton, Angelyn; Shapiro, Julia; Wong, Shirley; Azad, Arun; Kwan, Edmond; Spain, Lavinia; Muthusamy, Arun; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Joshua, Anthony M.; Pook, David; Gibbs, Peter; Tran, Ben; Weickhardt, Andrew Journal: Asia-Pacific journal of clinical oncology Issue: Volume 17:Issue 1(2021) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗